Circulating metabolites, genetics and lifestyle factors in relation to future risk of type 2 diabetes Nature Nawigacja wpisu Anavex Joins ACCESS-AD, a Major Initiative Funded by the European Commission, Through the Clinical Evaluation of Blarcamesine as Part of a Precision Medicine Approach in Alzheimer’s Disease – Anavex Life Sciences A new diet option for mild-to-moderate Crohn’s disease – Stanford Medicine
